{"DataElement":{"publicId":"2922829","version":"1","preferredName":"Temporomandibular Joint Disorder Pain Treatment Prescription Anti-inflammatory Administered Type","preferredDefinition":"the type prescription anti-inflammatory treatment for pain from any condition affecting the anatomic and functional characteristics of the temporomandibular joint.","longName":"TMJD_P_TX_P_AI_A_TP","context":"NIDCR","contextVersion":"1","DataElementConcept":{"publicId":"2903832","version":"1","preferredName":"Temporomandibular Joint Disorder Pain Treatment Prescription Anti-inflammatory Administered","preferredDefinition":"information related to prescription anti-inflammatory treatment for pain from any condition affecting the anatomic and functional characteristics of the temporomandibular joint.","longName":"TMJD_PAI_TX_P_AI_AD","context":"NIDCR","contextVersion":"1","ObjectClass":{"publicId":"2862211","version":"1","preferredName":"Temporomandibular Joint Disorder Pain Therapy","preferredDefinition":"Any condition affecting the anatomic and functional characteristics of the temporomandibular joint.:An unpleasant sensation induced by noxious stimuli and generally received by specialized nerve endings.:An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"C63709:C3303:C15368","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Temporomandibular Joint Disorder","conceptCode":"C63709","definition":"A disorder that affects the masticatory muscles and temporomandibular joint.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Pain","conceptCode":"C3303","definition":"The sensation of discomfort, distress, or agony, resulting from the stimulation of specialized nerve endings.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapy","conceptCode":"C15368","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68295BCC-97AD-8D2C-E040-BB89AD4314FA","latestVersionIndicator":"Yes","beginDate":"2009-04-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-04-22","modifiedBy":"ONEDATA","dateModified":"2009-04-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2903830","version":"1","preferredName":"Prescription Anti-inflammatory Administered","preferredDefinition":"A doctor's order for medicine or another intervention.:Having to do with reducing inflammation.:Given.","longName":"C28180:C28347:C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prescription","conceptCode":"C28180","definition":"A verbal or written order given by an authorized person instructing a patient to obtain and use a medical device, prescription or undergo a procedure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Anti-inflammatory","conceptCode":"C28347","definition":"Having to do with reducing inflammation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6CF21001-CF56-76A9-E040-BB89AD437ABF","latestVersionIndicator":"Yes","beginDate":"2009-06-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-06-22","modifiedBy":"ONEDATA","dateModified":"2009-06-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6CF21001-CF67-76A9-E040-BB89AD437ABF","latestVersionIndicator":"Yes","beginDate":"2009-06-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-06-22","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2922825","version":"1","preferredName":"Anti-inflammatory Medication Administered Type","preferredDefinition":"the type of anti-inflammatory medication administered.","longName":"ANTIINF_MED_ADMIN_TP","context":"NIDCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"None","valueDescription":"None at all","ValueMeaning":{"publicId":"2574138","version":"1","preferredName":"None at all","longName":"2574138","preferredDefinition":"No person or thing, nobody, not any.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EEA7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"CLOHNES","dateModified":"2022-08-12","changeDescription":null,"administrativeNotes":"8/12/22 added alt VM for Alliance cjl;","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6FB34A35-F616-0250-E040-BB89AD4308FF","beginDate":"2009-07-27","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-07-27","modifiedBy":"ONEDATA","dateModified":"2009-07-27","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2559653","version":"1","preferredName":"Other","longName":"2559653","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B612-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6FB34A35-F620-0250-E040-BB89AD4308FF","beginDate":"2009-07-27","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-07-27","modifiedBy":"ONEDATA","dateModified":"2009-07-27","deletedIndicator":"No"},{"value":"Ibuprofen","valueDescription":"Ibuprofen","ValueMeaning":{"publicId":"2578121","version":"1","preferredName":"Ibuprofen","longName":"2578121v1.00","preferredDefinition":"A propionic acid derivate and nonsteroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic, and antipyretic effects. Ibuprofen inhibits the activity of cyclo-oxygenase I and II, resulting in a decreased formation of precursors of prostaglandins and thromboxanes. This leads to decreased prostaglandin synthesis, by prostaglandin synthase, the main physiologic effect of ibuprofen. Ibuprofen also causes a decrease in the formation of thromboxane A2 synthesis, by thromboxane synthase, thereby inhibiting platelet aggregation. (NCI05)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ibuprofen","conceptCode":"C561","definition":"A propionic acid derivate and nonsteroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic, and antipyretic effects. Ibuprofen inhibits the activity of cyclo-oxygenase I and II, resulting in a decreased formation of precursors of prostaglandins and thromboxanes. This leads to decreased prostaglandin synthesis, by prostaglandin synthase, the main physiologic effect of ibuprofen. Ibuprofen also causes a decrease in the formation of thromboxane A2 synthesis, by thromboxane synthase, thereby inhibiting platelet aggregation. (NCI05)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FE36-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-06","modifiedBy":"MMADDINENI","dateModified":"2023-08-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6FB34A35-F62A-0250-E040-BB89AD4308FF","beginDate":"2009-07-27","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-07-27","modifiedBy":"ONEDATA","dateModified":"2009-07-27","deletedIndicator":"No"},{"value":"Naprosyn","valueDescription":"Naproxen","ValueMeaning":{"publicId":"2922826","version":"1","preferredName":"Naproxen","longName":"2922826","preferredDefinition":"A propionic acid derivative and a non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, antipyretic and analgesic activities. Naproxen inhibits the activity of the enzymes cyclo-oxygenase I and II, resulting in a decreased formation of precursors of prostaglandins and thromboxanes. The resulting decrease in prostaglandin synthesis is responsible for the therapeutic effects of naproxen. Naproxen also causes a decrease in the formation of thromboxane A2 synthesis, by thromboxane synthase, thereby inhibiting platelet aggregation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Naproxen","conceptCode":"C680","definition":"A propionic acid derivative and a non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, antipyretic and analgesic activities. Naproxen inhibits the activity of the enzymes cyclo-oxygenase I and II, resulting in a decreased formation of precursors of prostaglandins and thromboxanes. The resulting decrease in prostaglandin synthesis is responsible for the therapeutic effects of naproxen. Naproxen also causes a decrease in the formation of thromboxane A2 synthesis, by thromboxane synthase, thereby inhibiting platelet aggregation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FB34A35-F634-0250-E040-BB89AD4308FF","latestVersionIndicator":"Yes","beginDate":"2009-07-27","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-07-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6FB34A35-F64C-0250-E040-BB89AD4308FF","beginDate":"2009-07-27","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-07-27","modifiedBy":"ONEDATA","dateModified":"2009-07-27","deletedIndicator":"No"},{"value":"Aspirin","valueDescription":"Acetylsalicylic Acid","ValueMeaning":{"publicId":"2922827","version":"1","preferredName":"Acetylsalicylic Acid","longName":"2922827","preferredDefinition":"An orally administered non-steroidal antiinflammatory agent that inhibits cyclooxygenase synthesis of prostaglandin, preventing the formation of platelet aggregation and inflammation. It has analgesic and antipyretic properties. (NCI04)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Aspirin","conceptCode":"C287","definition":"An orally administered non-steroidal antiinflammatory agent. Acetylsalicylic acid binds to and acetylates serine residues in cyclooxygenases, resulting in decreased synthesis of prostaglandin, platelet aggregation, and inflammation. This agent exhibits analgesic, antipyretic, and anticoagulant properties.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FB34A35-F657-0250-E040-BB89AD4308FF","latestVersionIndicator":"Yes","beginDate":"2009-07-27","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-07-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6FB34A35-F670-0250-E040-BB89AD4308FF","beginDate":"2009-07-27","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-07-27","modifiedBy":"ONEDATA","dateModified":"2009-07-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FB34A35-F602-0250-E040-BB89AD4308FF","latestVersionIndicator":"Yes","beginDate":"2009-07-27","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-07-27","modifiedBy":"REEVESD","dateModified":"2014-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2857180","version":"1","longName":"Type of Category","context":"NIDCR","ClassificationSchemeItems":[{"publicId":"2812084","version":"1","longName":"Diagnostic","context":"NIDCR"},{"publicId":"2812085","version":"1","longName":"Preventive","context":"NIDCR"},{"publicId":"2812094","version":"1","longName":"Orthodontics","context":"NIDCR"}]},{"publicId":"2857182","version":"1","longName":"Protocol Forms","context":"NIDCR","ClassificationSchemeItems":[{"publicId":"2812041","version":"1","longName":"NIDCR","context":"NIDCR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"NSAID(s) you prefer to prescr","type":"Preferred Question Text","description":"NSAID(s) you prefer to prescribe","url":null,"context":"NIDCR"}],"origin":"PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"6FB34A35-F67A-0250-E040-BB89AD4308FF","latestVersionIndicator":"Yes","beginDate":"2009-07-27","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-07-27","modifiedBy":"ALAIS","dateModified":"2011-08-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}